Cardiovascular disease deaths involving substance use rose an average of 4% per year from 1999 to 2019, despite a drop in overall cardiovascular disease deaths, according to new research published today in the Journal of ...
Jan 10, 2024
0
0
Children who develop neuroblastomas, a rare form of cancer which develops in nerve cells, may benefit from receiving certain anti-tumor drugs as well as chemotherapy, a new trial has found.
Jan 9, 2024
0
0
For patients with knee osteoarthritis (KOA), microfragmented adipose tissue (MFAT) injection with arthroscopic surgery is associated with improved midterm clinical outcomes, according to a study published online Dec. 26 in ...
Jan 9, 2024
0
1
Asthma and chronic obstructive pulmonary disease (COPD) are two of the most common lung diseases worldwide, and exacerbation of these conditions can negatively impact health and increase health care costs. A new study shows ...
Jan 9, 2024
0
11
Endocrine resistance—a major cause of breast cancer deaths—can be underpinned by an epigenetic change called DNA methylation, researchers at the Garvan Institute of Medical Research have discovered. The team successfully ...
Jan 9, 2024
0
39
Cedars-Sinai Cancer investigators have analyzed the cells within triple-negative breast cancer tumors before and after radiation therapy with immunotherapy, identifying three patient groups with different responses to the ...
Jan 8, 2024
0
43
In social media posts on the community network Reddit, users reported reduced cravings for alcohol when taking drugs intended to treat type 2 diabetes and obesity.
Jan 8, 2024
0
34
A recent study found changes in blood flow in the retina could explain why some migraine patients experience visual symptoms. The findings could represent a long-sought observable marker for migraines that doctors can use ...
Jan 7, 2024
0
1
More than 103,000 people in the U.S. are waiting for an organ transplant, according to the Organ Procurement and Transplantation Network. Nearly 60% of people on transplant waiting lists come from minority communities.
Jan 5, 2024
0
1
A phase III LIBRETTO-431 multicenter study has evaluated the efficacy and safety of selpercatinib compared to control treatment, which consisted of platinum-based chemotherapy associated or not with pembrolizumab (immune ...
Jan 5, 2024
0
1
